Diagenode launches a complete portfolio for bisulfite sequencing solutions
Denville, New Jersey (PRWEB) July 22, 2015 -- Diagenode, Inc., a leading global provider of shearing technologies such as the Bioruptor® and complete solutions for epigenetics research, recently launched a complete product line for bisulfite sequencing, complementing the company’s current DNA methylation product line. The new portfolio includes the comprehensive Premium Reduced Representation Bisulfite Sequencing (RRBS) Kit and the Premium Whole Genome Bisulfite Sequencing (WGBS) Kit. Diagenode also offers both a bisulfite conversion kit for gene-specific analysis and a commonly cited DNA methylation immunoprecipitation solution.
“Our RRBS kit has several unique features that are key for customers studying DNA methylation,” said Raphael Werding, Senior Product Manager at Diagenode. “It provides superior coverage at 4 million CpGs compared to similar technologies like the 450K Infinium bead array from Illumina. It has shown excellent results using low input samples as well as with FFPE and cancer samples. This validated kit has been designed to provide minimal degradation and bias compared to other solutions, providing researchers with the most robust RRBS technique.”
In addition, the RRBS kit is the only comprehensive solution available with all the relevant reagents required for start to finish RRBS -- bisulfite conversion reagents, MspI enzyme, library preparation reagents including barcodes, and spike-in controls.
“Diagenode’s DNA methylation product portfolio addresses the broad needs of DNA methylation research,” said Didier Allaer, CEO of Diagenode. “Our latest addition of our bisulfite sequencing offerings represents our dedication to providing a complete suite of products for DNA methylation research.”
More information on Diagenode’s DNA methylation products and RRBS solution can be found at http://www.diagenode.com/en/landing-pages/rrbs.php
About Diagenode, Inc.:
Diagenode is a leading provider of complete solutions for epigenetics research and sample preparation. The company has developed both shearing solutions for a number of applications as well as a comprehensive approach to gain new insights into epigenetic studies. The company offers innovative shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include a unique, full automation system, the industry’s most validated antibodies, and the Megaruptor® shearing system for long fragment generation in sequencing. For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.
Didier Allaer, Diagenode, Inc., +1 8587747501, [email protected]
Share this article